KR20110075593A - Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease - Google Patents
Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease Download PDFInfo
- Publication number
- KR20110075593A KR20110075593A KR1020090132085A KR20090132085A KR20110075593A KR 20110075593 A KR20110075593 A KR 20110075593A KR 1020090132085 A KR1020090132085 A KR 1020090132085A KR 20090132085 A KR20090132085 A KR 20090132085A KR 20110075593 A KR20110075593 A KR 20110075593A
- Authority
- KR
- South Korea
- Prior art keywords
- garlic
- improvement
- bellflower
- extract
- functional food
- Prior art date
Links
- 240000002234 Allium sativum Species 0.000 title claims abstract description 41
- 239000000284 extract Substances 0.000 title claims abstract description 41
- 235000004611 garlic Nutrition 0.000 title claims abstract description 40
- 235000013376 functional food Nutrition 0.000 title claims abstract description 15
- 201000010099 disease Diseases 0.000 title claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 6
- 244000274050 Platycodon grandiflorum Species 0.000 title abstract description 5
- 235000006753 Platycodon grandiflorum Nutrition 0.000 title abstract description 5
- 230000000241 respiratory effect Effects 0.000 title description 3
- 210000000056 organ Anatomy 0.000 title description 2
- 230000003115 biocidal effect Effects 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 239000012141 concentrate Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 claims abstract description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 6
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 6
- 235000009566 rice Nutrition 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- 244000088415 Raphanus sativus Species 0.000 claims abstract 2
- 206010011224 Cough Diseases 0.000 claims description 41
- 208000006673 asthma Diseases 0.000 claims description 15
- 206010006451 bronchitis Diseases 0.000 claims description 15
- 206010068319 Oropharyngeal pain Diseases 0.000 claims description 12
- 201000007100 Pharyngitis Diseases 0.000 claims description 12
- 230000002265 prevention Effects 0.000 claims description 12
- 244000241838 Lycium barbarum Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 206010036790 Productive cough Diseases 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 208000024794 sputum Diseases 0.000 claims description 7
- 210000003802 sputum Anatomy 0.000 claims description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 5
- 208000019695 Migraine disease Diseases 0.000 claims description 3
- 206010027599 migraine Diseases 0.000 claims description 3
- 230000005070 ripening Effects 0.000 claims description 2
- 241000332371 Abutilon x hybridum Species 0.000 claims 5
- 235000020706 garlic extract Nutrition 0.000 abstract description 15
- 239000006000 Garlic extract Substances 0.000 abstract description 9
- 239000004615 ingredient Substances 0.000 abstract description 8
- 230000032683 aging Effects 0.000 abstract description 4
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 3
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 244000131415 Zanthoxylum piperitum Species 0.000 abstract 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 abstract 1
- 235000008504 concentrate Nutrition 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 241000703121 Campanula rotundifolia Species 0.000 description 48
- 208000024891 symptom Diseases 0.000 description 19
- 241000411851 herbal medicine Species 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 241000208340 Araliaceae Species 0.000 description 9
- 206010006458 Bronchitis chronic Diseases 0.000 description 7
- 208000023819 chronic asthma Diseases 0.000 description 7
- 208000007451 chronic bronchitis Diseases 0.000 description 7
- 208000013116 chronic cough Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 241000383638 Allium nigrum Species 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 235000006694 eating habits Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000220259 Raphanus Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- -1 purified Substances 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 206010038687 Respiratory distress Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940092385 radish extract Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000008729 scordinin Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000123667 Campanula Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 208000001319 vasomotor rhinitis Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/08—Concentrating or drying of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
Description
본 발명은 도라지 및 마늘 추출물을 함유하는 호흡기질환의 예방 및 개선용 건강기능식품 조성물에 관한 것으로, 더욱 상세하게는 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하고 기타 미량의 한방 약재 성분인 인삼, 무, 구기자 및 산초에서 선택되는 1종 이상의 추출물을 더 혼합하여 천식, 기관지염, 인후염 등과 같은 호흡기질환 증상을 예방하고 개선할 수 있는 도라지 및 마늘 추출물을 함유하는 호흡기질환의 예방 및 개선을 위한 건강기능식품 조성물에 관한 것이다.The present invention relates to a health functional food composition for the prevention and improvement of respiratory diseases containing bellflower and garlic extract, more specifically ginseng, radish containing a bellflower and garlic mixed extract as an active ingredient and other trace herbal ingredients Health functional foods for the prevention and improvement of respiratory diseases containing bellflower and garlic extracts, which can prevent and improve symptoms of respiratory diseases such as asthma, bronchitis, and sore throat by further mixing one or more extracts selected from goji and goji It relates to a composition.
최근 산업경제의 발전으로 환경오염, 식생활의 변화로 호흡기질환이 급증하고 있다. 대표적인 호흡기질환인 천식은 호흡곤란, 기침, 색색거리는 거친 숨소리(천명) 등의 증상이 반복적, 발작적으로 나타내는 병증이다. 그러나, 실제로 천식 환자는 전형적인 천식의 증상 외에 비전형적인 증상을 호소하는 경우도 많다. 즉, 호흡곤란이나 쌕쌕거리는 숨소리 등의 증상은 없고 단지 마른기침만 반복적으로 나 타나는 경우, 가슴이 답답하거나 흉부 압박감을 호소하는 경우 또는 목구멍에 가래가 걸려있는 것 같은 증상만을 호소하는 경우도 있다.Recently, due to the development of the industrial economy, respiratory diseases are rapidly increasing due to environmental pollution and changes in diet. Asthma, a typical respiratory disease, is a condition in which respiratory distress, coughing, and colorful, rough breathing (wheezing) occur repeatedly and seizure. However, in fact, asthma patients often complain of atypical symptoms in addition to the typical symptoms of asthma. In other words, if there are no symptoms such as shortness of breath or wheezing, only a dry cough appears repeatedly, complains of chest tightness, chest tightness or sputum in the throat. .
기관지염은 급성과 만성으로 나누어지며, 만성 기침, 가래 및 운동 시 호흡곤란이 주 증상이다. 가래는 대개 하얀색이나 약간의 노란색을 띄는 점액성이며 아침에 많이 나오는 경향이 있다. 병이 진행할 경우 비교적 수개월에서 수년에 걸쳐 서서히 호흡곤란이 심해져 약간의 활동에도 호흡곤란을 느끼게 된다. 원인별로는 알레르기성, 감염성, 외상성 등이 있고, 병리학적으로는 카타르성, 화농성, 궤양성, 침윤성 등이 있다. 원인은 세균, 바이러스, 진균 등의 감염에 의한 것이 가장 많고, 평소에 감염되지 않은 사람도 전신의 저항력이 약화되었을 때에 감염되기 쉽다.Bronchitis is divided into acute and chronic. Chronic cough, sputum and dyspnea are the main symptoms. Sputum is usually white or slightly yellowish mucus and tends to appear a lot in the morning. As the disease progresses, respiratory distress gradually develops over several months and years, resulting in difficulty in breathing even with a slight activity. The causes are allergic, infectious, traumatic and the like, and pathologically catarrhal, purulent, ulcerative and invasive. The most common cause is infection by bacteria, viruses, fungi, and the like, and people who are not normally infected are susceptible to infection when the resistance of the whole body is weakened.
알레르기비염은 코 알레르기 또는 알레르기성 비염이라고도 하며, 증세는 갑자기 연속적으로 재채기를 하고, 수양성 비즙(맑은 콧물)이 다량으로 나오고 코가 막히며, 또한 동시에 머리가 무겁고 눈물이 나오기도 한다. 증세가 아주 비슷하면서 항원이 분명하지 않은 것을 혈관운동신경성 비염이라 한다. 즉, 하루로 보면 아침에 일어나서 몸이 일시적으로 식었을 때에 앞에서 말한 바와 같은 증세가 일어났다가 수 시간 만에 낫는 것도 있으며, 1년 중 환절기라든지 추운 계절에 많다. 흔히 코감기로 혼동되는데 감기와는 다르며, 천식이나 두드러기를 합병하는 수가 많다.Allergic rhinitis is also referred to as nasal allergy or allergic rhinitis, symptoms of sudden sneezing, watery nasal juice (clear runny nose), large amounts of nasal congestion, and heavy head and tears. The symptoms are very similar, but the antigen is not clear is called vasomotor rhinitis. In other words, when one wakes up in the morning and the body cools down temporarily, the symptoms mentioned above may occur and heal in a few hours. It is often confused with a cold, which is different from the common cold and often involves asthma or hives.
이상에서와 같이 천식, 급 만성기관지염, 알레르기성 비염 등의 호흡기 질환은 그 발병원인과 증상에 있어서 일부 차이가 있으며, 호흡기질환에 따라 신약개발 이 발전하고 있으나 일시적인 효과를 보일 뿐, 그 증상들은 날로 악화되어 문제점이 가중되고 있다.As mentioned above, respiratory diseases such as asthma, chronic bronchitis, and allergic rhinitis have some differences in their causes and symptoms, and new drug development is developing depending on the respiratory diseases, but the symptoms are temporary. Deterioration is exacerbating the problem.
합성화학 신약의 부작용과 내성을 없애기 위해 100% 천연물 성분으로 이러한 문제점을 해결하기 위해 약용식물을 이용하여 호흡기질환 치료 개선 조성물을 개발하고자 하였으며, 사용되는 대표적인 약재로서 도라지 및 마늘은 다음과 같은 효능이 있다.In order to solve this problem with 100% natural ingredients in order to eliminate the side effects and resistance of synthetic chemical new drugs, medicinal plants were used to develop a respiratory disease treatment-improving composition. have.
도라지(길경; 학명: Platycodon grandiflorum)는 한국, 중국, 일본 및 만주 등에 분포되어있으며, 초롱꽃과에 속하는 다년생초본으로 당질, 칼슘과 철분 등이 풍부하게 들어 있는 알칼리성 식품이다. 과학적 성분 분석결과 아린맛을 내는 라시코틴 사포닌은 호흡기와 순환기에 작용해 목, 기관지 보호에 도움을 준다. 한의학에서는 예부터 가래와 기침을 멎게 하는 약으로 사용하여 왔으며 기침, 가래, 코 막힘, 천식, 기관지염증, 인후통, 두통 등에 사용한다.Bellflower (Gilkyung; Platycodon grandiflorum ) is distributed in Korea, China, Japan, and Manchuria. It is a perennial herb belonging to the Campanula, an alkaline food rich in sugar, calcium and iron. Scientific analysis shows that arachnid saponin, which is aromatizing, acts on the respiratory and circulatory organs to help protect the neck and bronchus. Traditional Chinese medicine has been used to stop phlegm and cough. It is used for cough, phlegm, nasal congestion, asthma, bronchitis, sore throat and headache.
마늘(garlic; 학명: Allium sativum L.)은 백합과에 속한 다년생 식물로서, 마늘의 주성분은 알리신과 스코르디닌으로 알려져 있다. 피로회복, 혈액순환 및 신진대사를 촉진시키는 기능을 갖는 물질로서, 예로부터 마늘이 강장, 강정 식품으로 널리 알려지게 된 근간이 되고 있는 성분이다.Garlic ( Allium sativum L. ) is a perennial plant belonging to the family Liliaceae. The main components of garlic are known as allicin and scordinin. As a substance having a function of promoting fatigue recovery, blood circulation, and metabolism, garlic is a component that has been widely known as a tonic and gangjeong food since ancient times.
이에 본 발명자들은 천식, 기관지염 및 인후염 등과 같은 호흡기질환 증상을 예방 및/또는 개선할 수 있는 유효물질에 대해 꾸준히 연구한 결과, 도라지 및 마늘 혼합 추출물이 효과적인 것을 확인하고 본 발명을 완성하였다.Accordingly, the present inventors have steadily studied the effective substances that can prevent and / or improve symptoms of respiratory diseases such as asthma, bronchitis, and sore throat, and have confirmed that bellflower and garlic mixed extracts are effective and completed the present invention.
결국, 본 발명의 주된 목적은 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하는 호흡기질환 증상의 예방 및 개선을 위한 건강기능식품 조성물을 제공하는데 있다.After all, the main object of the present invention is to provide a dietary supplement for the prevention and improvement of symptoms of respiratory diseases containing bellflower and garlic mixed extract as an active ingredient.
또한, 본 발명은 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하는 호흡기질환 증상의 예방 및 개선을 위한 건강기능식품을 제공하는데 또 다른 목적이 있다.In addition, the present invention is another object to provide a health functional food for the prevention and improvement of symptoms of respiratory diseases containing bellflower and garlic mixed extract as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 천연물에서 유래한 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하는 호흡기질환의 예방 및 개선용 건강기능식품 조성물을 제공한다.In order to achieve the above object, the present invention provides a health functional food composition for the prevention and improvement of respiratory diseases containing bellflower and garlic mixed extract derived from natural products as an active ingredient.
본 발명에 있어서, 상기 도라지 및 마늘 혼합 추출물은, (1) 도라지 및 마늘을 자연 숙성시키는 단계; (2) 상기 자연 숙성된 도라지 및 마늘에 찹쌀 고두밥, 엿기름 및 물을 혼합하여 당화시키는 단계; 및 (3) 상기 당화된 엿기름 추출물을 여과하여 농축시키는 단계;를 포함하여 제조되는 것을 특징으로 하며, 상기 호흡기질환은 천식, 기관지염, 인후염. 기침, 가래 및 편두선염 중 어느 하나 이상의 질환을 포함할 수 있다.In the present invention, the bellflower and garlic mixed extract, (1) natural ripening bellflower and garlic; (2) saccharifying by mixing glutinous rice, malt and water in the naturally aged bellflower and garlic; And (3) filtering and concentrating the saccharified malt extract. The respiratory disease is asthma, bronchitis, and sore throat. Diseases of any one or more of cough, sputum and migraine.
또한, 본 발명의 다른 목적을 달성하기 위하여, 본 발명은 상기 본 발명에 따른 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하는 호흡기질환의 예방 및 개선용 건강식품을 제공한다.In addition, to achieve another object of the present invention, the present invention provides a health food for the prevention and improvement of respiratory diseases containing bellflower and garlic mixed extract according to the present invention as an active ingredient.
참고로, 본 출원은 경북해양바이오산업연구원의 기술지원사업으로 수행되었다.For reference, this application was performed as a technical support project of Gyeongbuk Marine Bioindustry Research Institute.
본 발명은 도라지 및 마늘의 효능을 인체에 적용시키기 위해 도라지의 쓴맛과 마늘의 매운맛과 특유의 냄새가 제거됨으로써, 합성 화학 신약의 부작용 없이 안전하게 음용할 수 있도록 제조할 수 있다.The present invention by removing the bitter taste of the bellflower and the spicy taste of garlic and the peculiar smell of bellflower in order to apply the efficacy of bellflower and garlic to the human body, it can be prepared to drink safely without the side effects of synthetic chemical new drugs.
또한, 본 발명은 도라지 및 마늘을 이용한 혼합 추출물에 기타 미량의 생약 성분들이 더 첨가되어 기관지염, 인후염 및 천식개선 등을 포함하는 호흡기질환 치료 개선제 조성물에 유용하게 사용될 수 있다.In addition, the present invention may further be added to the mixed extract using bellflower and garlic, and other trace herbal ingredients may be usefully used in the composition for treating respiratory diseases including bronchitis, sore throat and asthma improvement.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 천연물에서 유래한 도라지 및 마늘 혼합 추출물을 유효성분으로 함유하는 호흡기질환의 예방 및 개선용 건강기능식품 조성물을 제공한다.The present invention provides a health functional food composition for the prevention and improvement of respiratory diseases containing bellflower and garlic mixed extract derived from natural products as an active ingredient.
본 발명에서, 상기 도라지 및 마늘 혼합 추출물은, 도라지와 마늘의 독특한 쓴 맛을 제거하기 위하여 숙성 단계를 거치는 것을 특징으로 한다. 상기 숙성 단계는 도라지와 마늘을 잘 세척하여 물기를 제거한 후, 각각을 증숙기에 넣고 약 50 내지 80℃, 바람직하게는 60 내지 70℃의 온도 범위에서 1 내지 20일, 바람직하게는 7 내지 15일 동안 자연 숙성시켜 흑도라지, 흑마늘을 제조한 다음, 열풍건조기를 이용하여 80 내지 100℃에서 약 6 내지 24시간, 바람직하게는 10 내지 20시간 동안 건조시키는 것이 좋다.In the present invention, the bellflower and garlic mixed extract, characterized in that it undergoes a aging step to remove the unique bitter taste of bellflower and garlic. The aging step is to wash the bellflower and garlic well to remove water, put each in a steamer 1 to 20 days, preferably 7 to 15 days in the temperature range of about 50 to 80 ℃, preferably 60 to 70 ℃ It is preferable to produce black bellflower, black garlic by natural aging for about 6 to 24 hours, preferably 10 to 20 hours at 80 to 100 ℃ using a hot air dryer.
또한, 상기와 같이 제조된 흑도라지, 흑마늘은 찹쌀 고두밥과 엿기름 및 물과 혼합하여 당화시킨 다음 여과하고, 그 여과액을 농축하여 최종 추출물을 제조할 수 있다.In addition, the black bellflower and black garlic prepared as described above may be mixed with glutinous rice, malt and water, saccharified and filtered, and the filtrate may be concentrated to prepare a final extract.
본 발명에서 상기 '추출물'은 추출액, 정제물, 희석액, 농축액, 및 건조물을 모두 포함한다.In the present invention, the 'extract' includes all of the extract, purified, diluent, concentrate, and dried.
또한, 본 발명에서 상기 '호흡기질환'은 천식, 기관지염, 인후염, 기침, 가래, 편두선염 중 어느 하나 이상의 질환을 포함하며, 상기 질환의 증상을 예방, 개선 또는 증상의 경감을 의미한다.In addition, the 'respiratory disease' in the present invention includes any one or more diseases of asthma, bronchitis, sore throat, cough, sputum, migraine, and means to prevent, improve or reduce the symptoms of the disease.
본 발명의 건강기능식품 조성물은 또한, 상기 도라지 및 마늘 혼합 추출물에 더하여 기타 미량의 한방 약재 성분인 인삼, 무, 구기자 및 산초에서 선택되는 1종 이상을 더 함유할 수도 있다.The dietary supplement composition of the present invention may further contain at least one selected from ginseng, radish, goji berry and sancho in addition to the above-mentioned bellflower and garlic mixed extract.
이때, 상기 한방 약재 성분들은 추출물 형태로 포함되는 것이 바람직한데, 선택된 각각의 한방 생약재는, 시료 중량의 약 1 내지 20배, 바람직하게는 2 내지 10배 부피의 물, 탄소수 1 내지 4의 저급 알코올 또는 이들의 혼합용매, 바람직하게는 물로 30 내지 100℃, 바람직하게는 80 내지 100℃에서 약 0.1 내지 48시간, 바람직하게는 0.1 내지 24시간 동안 교반추출, 열수추출, 냉침추출, 가온추출, 환류냉각추출 또는 초음파추출 등의 추출방법을 사용하여 추출한 후 수득한 추출액을 여과, 감압농축 또는 건조하여 수득할 수 있다.At this time, the herbal medicine ingredients are preferably included in the form of an extract, each herbal medicine selected, about 1 to 20 times the weight of the sample, preferably 2 to 10 times the volume of water, lower alcohol of 1 to 4 carbon atoms Or a mixed solvent thereof, preferably water, at about 30 to 100 ° C., preferably at 80 to 100 ° C. for about 0.1 to 48 hours, preferably 0.1 to 24 hours, stirring extraction, hot water extraction, cold extraction, warm extraction, reflux The extract obtained after extraction using an extraction method such as cooling extraction or ultrasonic extraction may be obtained by filtration, concentration under reduced pressure or drying.
본 발명에 따른 도라지 및 마늘 혼합 추출물과 한방 약재 추출물들은 오랫동 안 생약으로 사용되어 오던 약재로부터 추출하였기 때문에 역시 독성 및 부작용 등의 문제가 거의 없으므로 예방을 목적으로 장기간 복용 시에도 안심하고 사용할 수 있다.Bellflower and garlic mixture extract and herbal medicine extracts according to the present invention can be used safely for long-term administration for the purpose of prevention because there is also almost no problems such as toxicity and side effects because it is extracted from the medicine that has been used as a herbal medicine for a long time.
본 발명의 도라지 및 마늘 혼합 추출물 및 한방 약재 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강기능성 식품류 등이 있다. 또한, 호흡기질환의 예방 및 개선 효과를 목적으로 식품 또는 음료에 첨가될 수 있다.Foods to which the bellflower and garlic mixture extract and herbal medicine extract of the present invention can be added include, for example, various foods, beverages, gums, teas, vitamin complexes, and health functional foods. It may also be added to food or beverages for the purpose of preventing and improving respiratory diseases.
이때, 식품 또는 음료 중의 상기 추출물의 양은 일반적으로 본 발명의 건강기능식품 조성물은 전체 식품 중량의 0.01 내지 99.99중량%로 첨가할 수 있으며, 건강음료 조성물은 100㎖를 기준하여 0.02 내지 5g의 비율로 첨가할 수 있다.At this time, the amount of the extract in the food or beverage is generally added to the dietary supplement composition of the present invention 0.01 to 99.99% by weight of the total food weight, the health beverage composition in a ratio of 0.02 to 5g based on 100ml Can be added.
본 발명의 건강기능식품은 정제, 캡슐제, 환제, 액제 등의 형태를 포함하고, 본 발명의 건강음료 조성물은 지시된 비율로 필수 성분으로서 상기 도라지 및 마늘 혼합 추출물을 함유하는 외에 액체성분에는 특별한 제한은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 더 함유할 수 있다.The health functional food of the present invention includes the form of tablets, capsules, pills, liquids, and the like, and the health beverage composition of the present invention contains the bellflower and garlic mixed extracts as essential ingredients in the indicated ratio, There is no limitation and may further contain various flavors or natural carbohydrates, such as ordinary drinks.
상술한 천연 탄수화물의 예로는 모노사카라이드, 예를 들어, 포도당, 과당 등의 다시카라이드, 예를 들어 말토스, 수크로오스 등 및 폴라사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 솔비톨, 에리트리톨 등의 당알콜이다. 상술한 것에 더하여 향미제로서 천연 향미제, 타우마틴, 스테비아 추출물, 예를 들어 레바우디오시드 A, 글리시르히진 등 및 합성 향미제, 사카린, 아스파르탐 등을 유리하게 사용할 수 있다.Examples of the natural carbohydrates mentioned above include monosaccharides such as glucose, fructose and the like, such as resaccharides such as maltose, sucrose and the like and conventional sugars such as polysaccharides such as dextrin, cyclodextrin and the like; Sugar alcohols such as xylitol, sorbitol, and erythritol. In addition to the above, natural flavors, taumartins, stevia extracts such as rebaudioside A, glycyrrhizin and the like and synthetic flavors, saccharin, aspartame and the like can be advantageously used as flavoring agents.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 성분을 독립적으로 또는 조합하여 사용할 수 있으며, 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100중량부에 대해 0 내지 약 20중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic and natural flavors, colorants and enhancers (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and salts thereof. , Organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like. These components may be used independently or in combination, and the proportion of such additives is not so critical but is usually selected in the range of 0 to about 20 parts by weight relative to 100 parts by weight of the composition of the present invention.
이하, 실시 예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to the following examples. It is to be understood by those skilled in the art that these examples are for illustrative purposes only and that the scope of the present invention is not construed as being limited by these examples.
먼저, 본 발명에 따른 호흡기질환치료 개선제 조성물에 포함되는 각종 성분재료의 주성분과 효능 내지는 용도는 하기 표 1에 나타내었다.First, the main components and the efficacy or use of various ingredients included in the respiratory disease treatment improving agent composition according to the present invention are shown in Table 1 below.
[표 1]TABLE 1
상기 표 1에 나타난 재료에 대한 자료는 동의보감, 향약집성방, 본초서 등을 참조하여 나타낸 것이다.The data on the material shown in Table 1 is shown with reference to the agreement of bogam, medicinal herbs, herbal papers and the like.
실시예 1. 도라지 및 마늘 혼합 추출물의 제조Example 1 Preparation of Bellflower and Garlic Mix Extracts
깨끗하게 세척한 5년생 도라지와 외피 및 내피가 제거된 생마늘을 증숙기에 넣고 70℃의 온도로 10일간 숙성시켜 흑도라지, 흑마늘을 제조한 다음, 80~100℃의 온도로 유지되는 열풍건조기에서 약 15시간 동안 건조시켰다.Put freshly washed five-year-old bellflower and fresh garlic, which had the outer skin and the inner skin removed, into a steamer and aged at 70 ℃ for 10 days to produce black bellflower, black garlic, and then in a hot air dryer maintained at a temperature of 80 ~ 100 ℃. Dried for hours.
상기 흑도라지, 흑마늘은 찹쌀 고두밥과 엿기름 및 물과 혼합하여 65~70℃에서 9~10시간 동안 발효하여 당화시킨 다음 찌꺼기는 걸러 내고, 그 여액을 고형분 함량이 20%가 될 때까지 농축하여 최종 도라지 및 마늘 혼합 추출물을 제조하였다.The black bellflower and black garlic are mixed with glutinous rice, malt and water, fermented at 65-70 ° C. for 9-10 hours and then saccharified, and the filtrate is concentrated until the solid content is 20%. Bellflower and garlic mixed extracts were prepared.
이때, 흑도라지, 흑마늘, 찹쌀 고두밥, 엿기름 및 물은 각각 1 : 1 : 3 : 1.5 : 7의 중량비로 첨가하였다.At this time, black bellflower, black garlic, glutinous rice dumplings, malt and water were added in a weight ratio of 1: 1: 3: 1.5: 7, respectively.
실시예 2. 도라지 및 마늘 혼합 추출물과 인삼 농축액을 혼합한 생약 제조Example 2. Preparation of herbal medicine mixed bellflower and garlic mixture extract and ginseng concentrate
인삼 50g에 물 400㎖를 넣고, 가압 추출장치에서 가열하여 내부 온도 100℃에서 6시간 유지하고, 실온으로 냉각한 후 여과하여 인삼 추출액을 수득하였다.400 g of water was added to 50 g of ginseng, heated in a pressure extractor, maintained at an internal temperature of 100 ° C. for 6 hours, cooled to room temperature, and filtered to obtain a ginseng extract.
상기 인삼 농축액은 상기 실시예 1의 도라지 및 마늘 혼합 추출물과 동량으로 배합하여 생약을 제조하되, 배합공정은 95℃에서 3시간동안 진행하였다. The ginseng concentrate was prepared in the same amount as the bellflower and garlic mixture extract of Example 1 to prepare a herbal medicine, but the blending process was carried out at 95 ℃ for 3 hours.
실시예 3. 도라지 및 마늘 혼합 추출물과 무 농축액을 혼합한 생약 제조 Example 3 Preparation of Herbal Medicine Mixed with Bellflower and Garlic Extracts
무 농축액은 무 25kg을 추출기에 넣어 80℃의 고온으로 3시간 동안 달여서 제조하였다. 이때 찌거기인 폐기물이 20~30% 생기므로 추출량은 70~80% 정도이다.The concentrate was prepared by putting 25 kg of radish into the extractor for 3 hours at a high temperature of 80 ° C. At this time, 20 ~ 30% of waste is generated, so the extraction amount is about 70 ~ 80%.
상기 제조된 무즙 농축액을 도라지 및 마늘 혼합 추출물 동량으로 배합하였으며, 상기 배합공정은 95℃에서 3시간 동안 진행하였다.The prepared juice-free concentrate was formulated in the same amount of bellflower and garlic mixed extract, the blending process was performed at 95 ℃ for 3 hours.
실시예 4. 도라지 및 마늘 혼합 추출물과 구기자 농축액을 혼합한 생약 제조Example 4 Preparation of Herbal Medicine Combining Bellflower and Garlic Extracts and Wolfberry Concentrate
구기자 3 kg을 채취하여 물로 세척하고 5일간 실온에서 자연 건조시켜 수분을 제거한 후, 세절 또는 분쇄한 다음, 80g을 물 5ℓ에 넣고 100℃에서 가열한 후 끓기 시작하면 30분 후에 불을 끄고 식혔다. 이 때 끓인 추출물을 5회 반복하여 재추출하고, 구기자 농축액을 수득하였다.3 kg of goji berries were collected, washed with water, dried at room temperature for 5 days to remove moisture, and then chopped or pulverized. 80 g of water was added to 5 L of water, heated at 100 ° C., and boiled. At this time, the boiled extract was repeatedly extracted five times to obtain a goji berry concentrate.
상기 구기자 농축액은 도라지 및 마늘 혼합 추출물과 동량으로 배합하였으며, 상기 배합공정은 95℃에서 3시간 동안 진행하였다.The goji berry concentrate was combined with the bellflower and garlic mixture extract in the same amount, the blending process was carried out at 95 ℃ for 3 hours.
실시예 5. 도라지 및 마늘 혼합 추출물과 산초 농축액을 혼합한 생약 제조Example 5 Preparation of Herbal Medicine Combining Bellflower and Garlic Extracts and Sancho Concentrate
산초나무를 종자와 종자를 제외한 부분(뿌리, 줄기, 가지, 잎, 열매껍질)으로 분류하여 건조한 다음 각각 파쇄하였다. 각 파쇄물에 증류수 10 중량부를 가하고, 100℃로 감압농축한 다음 추출물을 여과지로 여과하였다. 여과액은 재차 회전진공증발기를 이용하여 감압여과한 다음 1/10 부피로 농축하여 산초 농축액을 제조한 후, 도라지 및 마늘 혼합 추출물과 동량으로 배합하였으며, 상기 배합공정은 95℃에서 3시간 동안 진행하였다.The Japanese herb was classified into seeds and parts except seeds (roots, stems, branches, leaves, fruit bark), dried, and then crushed. 10 parts by weight of distilled water was added to each crushed product, concentrated under reduced pressure at 100 ° C, and the extract was filtered through a filter paper. The filtrate was filtered under reduced pressure using a rotary vacuum evaporator again, concentrated to 1/10 volume to prepare an acetic acid concentrate, and then blended in the same amount as the bellflower and garlic mixed extract, and the blending process was performed at 95 ° C. for 3 hours. It was.
실험 예 1. 도라지 및 마늘 추출물에 대한 관능평가Experimental Example 1. Sensory Evaluation of Bellflower and Garlic Extracts
호흡기질환 중증환자 15세~70세 피검자 증상별 20명을 대상으로 하였다. 상기 실시예 1에서 제조한 도라지 및 마늘 추출물을 실험 대상(20명)에게 일정 기간 섭취하게 하고, 섭취 기간 경과에 따른 호전 상태를 조사하였다. 이 때 각 실험 대상은 1일 2 회 복용하였고, 실험기간 중 모든 대상은 기존의 생활 방식 및 식습관을 유지하였다.Twenty patients with severe respiratory disease aged 15-70 years old were included. The bellflower and garlic extract prepared in Example 1 was ingested for a certain period of time to the test subjects (20 people), and the state of improvement over the intake period was investigated. At this time, each test subject was taken twice a day, and all subjects maintained their existing lifestyle and eating habits during the test period.
1주에서 1년간 복용한 결과, 하기 표 2에 나타난 바와 같이 완쾌 효과를 보였다.As a result of taking 1 week to 1 year, as shown in Table 2 showed a relaxation effect.
[표 2]TABLE 2
(조금호전; 기침횟수가 사용전보다 50% 정도 감소함, 호전; 기침횟수가 사용전보다 80% 정도 감소함, 완전호전; 기침횟수가 사용전보다 98% 정도 감소함, 완쾌: 기침횟수가 사용전보다 1주~1개월 이상동안 기침 등 각 증상이 없음)(Slightly improved; coughing rate is about 50% less than before use), improvement; coughing rate is about 80% less than before use, complete improvement; coughing rate is about 98% less than before use, relieved: coughing number is 1 No symptoms such as coughing for a week or more)
실험 예 2. 도라지 및 마늘 추출물에 인삼 농축액을 첨가한 관능평가Experimental Example 2. Sensory evaluation of ginseng and garlic extract added with ginseng concentrate
호흡기질환 중증환자 15세~70세 피검자 증상별 20명을 대상으로 하였다. 상기 실시예 1에서 제조한 도라지 및 마늘 추출물과 인삼 농축액을 혼합한 생약을 실험 대상(20명)에게 일정 기간 섭취하게 하고, 섭취 기간 경과에 따른 호전 상태를 조사하였다. 이 때 각 실험 대상은 1일 2 회 복용하였고, 실험기간 중 모든 대상은 기존의 생활 방식 및 식습관을 유지하였다.Twenty patients with severe respiratory disease aged 15-70 years old were included. The herbal medicine mixed with bellflower and garlic extract prepared in Example 1 and ginseng concentrate was ingested for a certain period of time for the test subjects (20), and the state of improvement over the intake period was investigated. At this time, each test subject was taken twice a day, and all subjects maintained their existing lifestyle and eating habits during the test period.
1주에서 1년간 복용한 결과, 하기 표 3에 나타난 바와 같이 만성기침, 만성천식에서 빠른 호전 효과를 보였다.As a result of taking 1 week to 1 year, as shown in Table 3, showed a rapid improvement in chronic cough, chronic asthma.
[표 3][Table 3]
(조금호전; 기침횟수가 사용전보다 50% 정도 감소함, 호전; 기침횟수가 사용전보다 80% 정도 감소함, 완전호전; 기침횟수가 사용전보다 98% 정도 감소함, 완쾌: 기침횟수가 사용전보다 1주~1개월 이상동안 기침 등 각 증상이 없음)(Slightly improved; coughing rate is about 50% less than before use), improvement; coughing rate is about 80% less than before use, complete improvement; coughing rate is about 98% less than before use, relieved: coughing number is 1 No symptoms such as coughing for a week or more)
실험 예 3. 도라지 및 마늘 추출물에 무즙 농축액을 첨가한 관능평가Experimental Example 3. Sensory evaluation of radish extract and radish extract
호흡기질환 중증환자 15세~70세 피검자 증상별 20명을 대상으로 하였다. 상기 실시예 1에서 제조한 도라지 및 마늘 추출물과 무즙 농축액을 혼합한 생약을 실험 대상(20명)에게 일정 기간 섭취하게 하고, 섭취 기간 경과에 따른 호전 상태를 조사하였다. 이 때 각 실험 대상은 1일 2 회 복용하였고, 실험기간 중 모든 대상은 기존의 생활 방식 및 식습관을 유지하였다.Twenty patients with severe respiratory disease aged 15-70 years old were included. The herbal medicines mixed with the bellflower and garlic extract prepared in Example 1 and the juice-free concentrate were ingested for a certain period of time for the test subjects (20), and the state of improvement over the intake period was investigated. At this time, each test subject was taken twice a day, and all subjects maintained their existing lifestyle and eating habits during the test period.
1주에서 1년간 복용한 결과, 하기 표 4에 나타난 바와 같이 만성천식에서 빠른 호전 효과를 보였다.As a result of taking 1 week to 1 year, as shown in Table 4 showed a rapid improvement in chronic asthma.
[표 4][Table 4]
(조금호전; 기침횟수가 사용전보다 50% 정도 감소함, 호전; 기침횟수가 사용전보다 80% 정도 감소함, 완전호전; 기침횟수가 사용전보다 98% 정도 감소함, 완쾌: 기침횟수가 사용전보다 1주~1개월 이상동안 기침 등 각 증상이 없음)(Slightly improved; coughing rate is about 50% less than before use), improvement; coughing rate is about 80% less than before use, complete improvement; coughing rate is about 98% less than before use, relieved: coughing number is 1 No symptoms such as coughing for a week or more)
실험 예 4. 도라지 및 마늘 추출물에 구기자 농축액을 첨가한 관능평가Experimental Example 4. Sensory evaluation of Goji berries with garlic extract
호흡기질환 중증환자 15세~70세 피검자 증상별 20명을 대상으로 하였다. 상기 실시예 1에서 제조한 도라지 및 마늘 추출물과 구기자 농축액을 혼합한 생약을 실험 대상(20명)에게 일정 기간 섭취하게 하고, 섭취 기간 경과에 따른 호전 상태를 조사하였다. 이 때 각 실험 대상은 1일 2 회 복용하였고, 실험기간 중 모든 대 상은 기존의 생활 방식 및 식습관을 유지하였다.Twenty patients with severe respiratory disease aged 15-70 years old were included. The herbal medicines mixed with bellflower and garlic extract prepared in Example 1 and goji berry concentrate were ingested for a certain period of time for the test subjects (20), and the state of improvement over the intake period was investigated. At this time, each subject was taken twice a day, and all subjects maintained their existing lifestyle and eating habits during the experiment.
1주에서 1년간 복용한 결과, 하기 표 5에 나타난 바와 같이 완쾌 효과를 보였다.As a result of taking 1 week to 1 year, as shown in Table 5 showed a relaxation effect.
[표 5]TABLE 5
(조금호전; 기침횟수가 사용전보다 50% 정도 감소함, 호전; 기침횟수가 사용전보다 80% 정도 감소함, 완전호전; 기침횟수가 사용전보다 98% 정도 감소함, 완쾌: 기침횟수가 사용전보다 1주~1개월 이상동안 기침 등 각 증상이 없음)(Slightly improved; coughing rate is about 50% less than before use), improvement; coughing rate is about 80% less than before use, complete improvement; coughing rate is about 98% less than before use, relieved: coughing number is 1 No symptoms such as coughing for a week or more)
실험 예 5. 도라지 및 마늘 추출물에 산초 농축액을 첨가한 관능평가Experimental Example 5. Sensory Evaluation of Addition of Sancho Concentrate to Bellflower and Garlic Extracts
호흡기질환 중증환자 15세~70세 피검자 증상별 20명을 대상으로 하였다. 상기 실시예 1에서 제조한 도라지 및 마늘 추출물과 산초 농축액을 혼합한 생약을 실험 대상(20명)에게 일정 기간 섭취하게 하고, 섭취 기간 경과에 따른 호전 상태를 조사하였다. 이 때 각 실험 대상은 1일 2 회 복용하였고, 실험기간 중 모든 대상은 기존의 생활 방식 및 식습관을 유지하였다.Twenty patients with severe respiratory disease aged 15-70 years old were included. The herbal medicines mixed with bellflower and garlic extract prepared in Example 1 and an acidic concentrate were fed to the test subjects (20 persons) for a certain period of time, and the state of improvement over the intake period was investigated. At this time, each test subject was taken twice a day, and all subjects maintained their existing lifestyle and eating habits during the test period.
1주에서 1년간 복용한 결과, 하기 표 6에 나타난 바와 같이 완쾌 효과를 보였다.As a result of taking 1 week to 1 year, as shown in Table 6 showed a relaxation effect.
[표 6]TABLE 6
(조금호전; 기침횟수가 사용전보다 50% 정도 감소함, 호전; 기침횟수가 사용전보다 80% 정도 감소함, 완전호전; 기침횟수가 사용전보다 98% 정도 감소함, 완쾌: 기침횟수가 사용전보다 1주~1개월 이상동안 기침 등 각 증상이 없음)(Slightly improved; coughing rate is about 50% less than before use), improvement; coughing rate is about 80% less than before use, complete improvement; coughing rate is about 98% less than before use, relieved: coughing number is 1 No symptoms such as coughing for a week or more)
이상, 본 발명의 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적인 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의해 의하여 정의된다고 할 것이다. As described above, specific portions of the contents of the present invention have been described in detail, and for those skilled in the art, these specific techniques are merely preferred embodiments, and the scope of the present invention is not limited thereto. Will be obvious. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090132085A KR20110075593A (en) | 2009-12-28 | 2009-12-28 | Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090132085A KR20110075593A (en) | 2009-12-28 | 2009-12-28 | Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110075593A true KR20110075593A (en) | 2011-07-06 |
Family
ID=44915573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090132085A KR20110075593A (en) | 2009-12-28 | 2009-12-28 | Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110075593A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160067553A (en) | 2014-12-04 | 2016-06-14 | 최철원 | A composition comprising medical herbs for improving respiratory diseases |
KR20160096967A (en) * | 2015-02-06 | 2016-08-17 | 주식회사 웰파이토 | Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum |
KR20200057306A (en) | 2018-11-16 | 2020-05-26 | (주)코레쉬텍 | Platycodon grandiflorum tea composition with increased the content of platycodin d or platycodin d3, and manufacturing method thereof |
KR102300766B1 (en) * | 2020-12-11 | 2021-09-13 | 유송미 | Composition of health functional beverage for improving rhinitis, removing sputum and improving respiratory disease |
KR20230071248A (en) | 2021-11-16 | 2023-05-23 | 김희정 | Method for manufacturing black bellflower extract using steaming and drying |
KR20240039622A (en) | 2022-09-19 | 2024-03-27 | 주식회사 오가닉위드 | Method for manufacturing black bellflower complex extract using deep sea water, steaming and drying |
-
2009
- 2009-12-28 KR KR1020090132085A patent/KR20110075593A/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160067553A (en) | 2014-12-04 | 2016-06-14 | 최철원 | A composition comprising medical herbs for improving respiratory diseases |
KR20160096967A (en) * | 2015-02-06 | 2016-08-17 | 주식회사 웰파이토 | Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum |
KR20200057306A (en) | 2018-11-16 | 2020-05-26 | (주)코레쉬텍 | Platycodon grandiflorum tea composition with increased the content of platycodin d or platycodin d3, and manufacturing method thereof |
KR102300766B1 (en) * | 2020-12-11 | 2021-09-13 | 유송미 | Composition of health functional beverage for improving rhinitis, removing sputum and improving respiratory disease |
KR20230071248A (en) | 2021-11-16 | 2023-05-23 | 김희정 | Method for manufacturing black bellflower extract using steaming and drying |
KR20240039622A (en) | 2022-09-19 | 2024-03-27 | 주식회사 오가닉위드 | Method for manufacturing black bellflower complex extract using deep sea water, steaming and drying |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20060132212A (en) | Aged concentrate of ginseng steamed red, and a preparation method thereof | |
KR20110075593A (en) | Antibiotic functional food containing extract of platycodon grandiflorum and garlic for preventing and improving respiratory organ disease | |
CN104336230A (en) | Mulberry leaf sweet tea and preparation method thereof | |
KR20130003520A (en) | Composition for preventing or relieving alcohol-induced hangover comprising medicinal herbs | |
CN104247913A (en) | Health rice vermicelli | |
KR20160071489A (en) | Composition for medicinal herbal tea and manufacturing method of composition for medicinal herbal by supercritical fluid extraction and manufacturing method of carbonated beverage and health beverage thereof | |
CN108523121A (en) | A kind of functional food and preparation method thereof of anti-haze clearing lung-heat | |
KR100912122B1 (en) | Composition of eel extract and red ginseng | |
KR101731899B1 (en) | health supplement food to Improve Respiratory Diseases and method for manufacturing the same | |
KR101337395B1 (en) | Composition for improving allergic rhinitis and production method thereof | |
KR101034986B1 (en) | Composition comprising the mixed herbal extract for relieving hangover | |
KR20100094015A (en) | Composition for asthma containing black platycodon and phellinus as effective ingredients | |
KR102282839B1 (en) | Composition for relieving or improving hangover | |
KR102136053B1 (en) | Composition for Removing Hangover Comprising Herb Extract and Beverage Thereof | |
CN103340411B (en) | Lung moistening oil tea camellia honey | |
US20080311229A1 (en) | Functional Food Composition For Treating Allergy, Natural Tea Using the Same and the Manufacturing Method Thereof | |
KR101198948B1 (en) | Energy drink composition and preparing method thereof | |
CN110742969A (en) | Preparation method of composition for improving sleep disorder caused by kidney yin deficiency | |
KR100642801B1 (en) | Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same | |
CN111296710A (en) | Pollen pini and spina date seed solid beverage and preparation method thereof | |
KR102494072B1 (en) | Composition for improving or preventing depression comprising herbal extracts and method for preparing thereof | |
CN110521888A (en) | A kind of sugarcane primary pulp drink and preparation method thereof | |
CN105875903A (en) | Tea product using hawthorn fruits as main raw materials and preparation method thereof | |
KR102577328B1 (en) | Composition for enhancing immunity comprising at least two herbal extracts as an active ingredient | |
KR102239159B1 (en) | Pharmaceutical composition comprising the extract of medicinal or edible natural products as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E601 | Decision to refuse application |